New research in JAMA Pediatrics highlights how treating and preventing obesity could significantly lower cases of prediabetes, hypertension, and dyslipidemia in younger populations.
A single capsule altering the gut microbiome via faecal microbiota transplantation (FMT) showed long-lasting metabolic improvements—potentially reducing diabetes and heart disease risk for years.